Developments in pharmacotherapeutic agents for hepatitis B – how close are we to a functional cure?

Author:

Khan Naoshin1,Almajed Mohamed Ramzi1,Fitzmaurice Mary Grace2,Jafri Syed-Mohammed3

Affiliation:

1. Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA

2. Pharmacy Department and Transplant Institute, Henry Ford Hospital, Detroit, MI, USA

3. Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference95 articles.

1. World Health Organization. Hepatitis B key facts. [cited 2022 Dec 27]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b

2. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

3. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis

4. Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis

5. Foundation HB. Approved drugs for adults. [cited 2022 Dec 27]. Available from: https://www.hepb.org/treatment-and-management/treatment/approved-drugs-for-adults/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3